Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.39 |
| ▸ | OTC | P00480 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.36 |
| ▸ | NPY4R | P50391 | 7/20 | 0.36 |
| ▸ | NPY1R | P25929 | 5/20 | 0.36 |
| ▸ | NPY2R | P49146 | 4/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.36 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.34 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.34 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.34 |
| ▸ | NOS1 | P29475 | 3/20 | 0.33 |
| ▸ | NOS3 | P29474 | 2/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | RRM1 | P23921 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Arginine SCHEMBL21081868 | 0.98 | DPP7 (0.38) | DPP7OTCALOX15MEN1CYP1A2 | |
| Arginine SCHEMBL4273378 | 0.98 | DPP7 (0.40) | DPP7OTCALOX15MEN1CYP1A2 | |
| Arginine SCHEMBL7713117 | 0.96 | DPP7 (0.39) | DPP7OTCALOX15MEN1CYP1A2 | |
| Arginine SCHEMBL21808680 | 0.96 | DPP7 (0.39) | DPP7OTCALOX15MEN1CYP1A2 | |
| Arginine SCHEMBL16194704 | 0.96 | DPP7 (0.39) | DPP7OTCALOX15MEN1CYP1A2 | |
| Arginine SCHEMBL3749742 | 0.96 | DPP7 (0.39) | DPP7OTCALOX15MEN1CYP1A2 | |
| Arginine SCHEMBL1766115 | 0.96 | DPP7 (0.39) | DPP7OTCALOX15MEN1CYP1A2 | |
| Arginine SCHEMBL6711066 | 0.96 | DPP7 (0.39) | DPP7OTCALOX15MEN1CYP1A2 | |
| Arginine SCHEMBL7154973 | 0.96 | DPP7 (0.39) | DPP7OTCALOX15MEN1CYP1A2 | |
| Arginine SCHEMBL9238731 | 0.96 | DPP7 (0.39) | DPP7OTCALOX15MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12521322-B2 | Foaming oral care compositions | THE PROCTER & GAMBLE COMPANY (US) | 2026-01-13 | — | — | US | claimed |
| EP-3400260-B2 | SCAVENGER COMPOSITIONS FOR SULFUR SPECIES | INNOPHOS INC (US) | 2025-03-19 | — | — | EP | claimed |
| CN-119632148-A | Powder-free granular composite premixed feed and preparation method thereof | 丰县新中牧饲料有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-118496683-A | Scavenger composition for sulfur species | 伊诺弗斯公司 | 2024-08-16 | — | — | CN | claimed |
| US-20240197578-A1 | Foaming Oral Care Compositions | PROCTER & GAMBLE (US) | 2024-06-20 | — | — | US | claimed |
| CN-118160928-A | Composition for promoting water supplementing and preparation method and application thereof | 南京盛德创赢生物科技有限公司 | 2024-06-11 | — | — | CN | claimed |
| EP-3359138-B1 | DIETARY SUPPLEMENTATION TO ACHIEVE OXY-REDOX HOMEOSTASIS AND EPIGENETIC STABILITY | PARTHENOGEN SAGL (CH) | 2024-04-24 | — | — | EP | claimed |
| US-11944694-B2 | Foaming oral care compositions | THE PROCTER & GAMBLE COMPANY (US) | 2024-04-02 | — | — | US | claimed |
| CN-112655846-B | Organic trace element composite package for shrimps and crabs as well as preparation method and application thereof | 长沙兴嘉生物工程股份有限公司 | 2023-10-31 | — | — | CN | claimed |
| WO-2023007088-A1 | FOOD SUPPLEMENT FOR COMBATING FEMALE AND MALE INFERTILITY | NURIBIOL (FR) | 2023-02-02 | — | — | WO | claimed |
| US-20040105894-A1 | Trace Metals synergized copper nucleotides and copper glycosides for anti-aging and antiviral compositions | GUPTA SHYAM K (US) | 2004-06-03 | — | — | US | claimed |
| US-20030211172-A1 | Composition and method for substantially reducing the deleterious effects of alcohol on the body | JONES JEREMY PARK (US) | 2003-11-13 | — | — | US | claimed |
| US-6447809-B1 | MIXTURES OF MICROCRYSTALLINE HYDROXYAPATITE, CHOLECALCIFEROL AND IPRIFLAVONE ADMINISTERED AS OSTEOBLASTS STIMULANTS FOR PREVENTION OF OSTEOPOROSIS | METAGENICS, INC. | 2002-09-10 | — | — | US | claimed |
| US-20020001632-A1 | Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer | REVEL CHASE (PA) | 2002-01-03 | — | — | US | claimed |
| US-20020001633-A1 | Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer | REVEL CHASE (US) | 2002-01-03 | — | — | US | claimed |
| EP-0672500-B1 | Polymeric mask for sandblasting and method for its use | AICELLO CHEMICAL CO (JP) | 2001-12-19 | — | — | EP | claimed |
| EP-0672500-A2 | Polymeric mask for sandblasting and method for its use | AICELLO CHEMICAL CO. LTD. (JP) | 1995-09-20 | — | — | EP | claimed |
| US-5234698-A | Increases amount of prostatic antibacterial factor | FAHIM MOSTAFA S (US) | 1993-08-10 | — | — | US | claimed |
| US-5071658-A | Increase antibacterial factor and inhibits growth; antiandrogen agent | FAHIM MOSTAFA S (US) | 1991-12-10 | — | — | US | claimed |
| US-4946688-A | ANTIGROWTH AGENTS | FAHIM MOSTAFA S (US) | 1990-08-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240197578-A1 | Foaming Oral Care Compositions | FOS, STOM, UGCG | DPP7 4174/4885OTC 245/4885ALOX15 1569/4885 |
| US-11944694-B2 | Foaming oral care compositions | FOS, STOM, UGCG | DPP7 4174/4885OTC 245/4885ALOX15 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.